Fund moves

BioMarin Pharmaceutical (BMRN)Rubric Capital Management LP exited its position 441K shares

Rubric Capital Management LP exited its position in BioMarin Pharmaceutical, per its Q2 2026 13F.

441K
Prior-quarter shares · no longer reported
Holdings as of
Jun 30, 2026
Filed
Aug 14, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. Aug 17, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
  2. Aug 30, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
  3. Sep 2, 2026Insider · 8 days before an 8-KOfficer sold ~$1.16M of BMRN shares in the open market
  4. Sep 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 10, 2026, the Board of Directors (the Board) of BioMarin Pharmaceutical Inc. (the Company) increased the size of the Board from ten to eleven members and appointed Robert Plenge, M.D., Ph.D., to the Board, to be effective September 10, 2026 (the Appointment Date).”
  5. Sep 24, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  6. Oct 6, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for BioMarin Pharmaceutical

For BioMarin Pharmaceutical, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 9 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BMRN page.

How this filing works

Other disclosures at BioMarin Pharmaceutical

Everything OQRO holds on this company is on its BMRN page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data